Renaissance Technologies - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 30 filers reported holding LIANBIO in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of LIANBIO
ValueSharesWeighting
Q4 2023$1,547
+267.5%
346,000
+22.4%
0.00%
+100.0%
Q3 2023$421
-40.1%
282,602
-8.4%
0.00%0.0%
Q2 2023$703
+21.0%
308,500
+4.2%
0.00%0.0%
Q1 2023$581
+21.8%
296,200
+1.9%
0.00%0.0%
Q4 2022$477
-99.9%
290,622
-7.7%
0.00%0.0%
Q3 2022$630,000
+377.3%
315,000
+417.2%
0.00%
Q2 2022$132,000
-2.9%
60,900
+66.7%
0.00%
Q1 2022$136,00036,5240.00%
Other shareholders
LIANBIO shareholders Q4 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$8,467,0004.92%
Perceptive Advisors 56,319,960$208,947,0004.18%
VR Adviser, LLC 5,378,341$19,954,0003.23%
SCHF (GPE), LLC 937,500$3,478,0001.08%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$12,296,0000.73%
RA Capital Management 7,655,015$28,400,0000.62%
Logos Global Management LP 412,837$1,532,0000.20%
Affinity Asset Advisors, LLC 325,000$1,206,0000.19%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,020,0000.14%
MYDA Advisors LLC 86,000$319,0000.13%
View complete list of LIANBIO shareholders